selection marker (Santa Cruz Biotechnology)
94
Structured Review
Santa Cruz Biotechnology
selection marker
Selection Marker, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+marker/CASC3+CRISPR%2FCas9+KO+Plasmid/pmc12997282-156-15-28
Average 94 stars, based on 1 article reviews
Selection Marker, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+marker/CASC3+CRISPR%2FCas9+KO+Plasmid/pmc12997282-156-15-28
Average 94 stars, based on 1 article reviews
selection marker - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Selection:Article Title: Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways Article Snippet: Adiponectin receptor (AdipoR1) was knocked out by a commercial AdipoR1 CRISPR/Cas9-KO plasmid (Santa Cruz, CA, USA). .. The insertion of the puromycin gene as a Article Title: MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections Article Snippet: After transfection and validation, cells were subjected to selection with 1 μg/mL puromycin (Fisher Scientific, Oxford, UK) and, once tested for the success of genetic modification, were routinely maintained in maintenance medium (with 0.1 μg/mL puromycin). .. A human MLN51 CRISPR transcription activation system, which comprised three plasmids, each carrying a different Marker:Article Title: Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways Article Snippet: Adiponectin receptor (AdipoR1) was knocked out by a commercial AdipoR1 CRISPR/Cas9-KO plasmid (Santa Cruz, CA, USA). .. The insertion of the puromycin gene as a Article Title: MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections Article Snippet: After transfection and validation, cells were subjected to selection with 1 μg/mL puromycin (Fisher Scientific, Oxford, UK) and, once tested for the success of genetic modification, were routinely maintained in maintenance medium (with 0.1 μg/mL puromycin). .. A human MLN51 CRISPR transcription activation system, which comprised three plasmids, each carrying a different Plasmid Preparation:Article Title: Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways Article Snippet: Adiponectin receptor (AdipoR1) was knocked out by a commercial AdipoR1 CRISPR/Cas9-KO plasmid (Santa Cruz, CA, USA). .. The insertion of the puromycin gene as a CRISPR:Article Title: MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections Article Snippet: After transfection and validation, cells were subjected to selection with 1 μg/mL puromycin (Fisher Scientific, Oxford, UK) and, once tested for the success of genetic modification, were routinely maintained in maintenance medium (with 0.1 μg/mL puromycin). .. A human MLN51 CRISPR transcription activation system, which comprised three plasmids, each carrying a different Activation Assay:Article Title: MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections Article Snippet: After transfection and validation, cells were subjected to selection with 1 μg/mL puromycin (Fisher Scientific, Oxford, UK) and, once tested for the success of genetic modification, were routinely maintained in maintenance medium (with 0.1 μg/mL puromycin). .. A human MLN51 CRISPR transcription activation system, which comprised three plasmids, each carrying a different |